BOI — Boiron SA Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedMid CapContrarian
- €677.65m
- €436.41m
- €534.24m
- 98
- 59
- 33
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.41 | ||
| PEG Ratio (f) | 7.97 | ||
| EPS Growth (f) | 1.84% | ||
| Dividend Yield (f) | 3.01% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.22 | ||
| Price to Tang. Book | 1.57 | ||
| Price to Free Cashflow | 16.9 | ||
| Price to Sales | 1.27 | ||
| EV to EBITDA | 4.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.73% | ||
| Return on Equity | 8.2% | ||
| Operating Margin | 11.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 604.21 | 557.12 | 513.58 | 455.2 | 534.24 | 556 | 580.7 | -2.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -21.58 | -29.14 | -38.31 | +11.61 | +64.11 | -7.48 | +16.28 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
Directors
- Thierry Boiron CHM (60)
- Valerie Lorentz-Poinsot CEO (52)
- Jean-Christophe Michel Bayssat DCE (58)
- Jacky Abecassis NED (79)
- Laurence Boiron NED (45)
- Michele Boiron NED (76)
- Christine Boutin NED (53)
- Jean-Pierre Boyer NED (75)
- Christine Boyer-Boiron NED (77)
- Stephanie Chesnot NED (49)
- Anabelle Flory-Boiron NED (43)
- Bruno Grange NED (68)
- Virginie Heurtaut NED (46)
- Sylvain Mossaz NED (45)
- Gregory Walter NED (43)
- Michel Bouissou NID (79)
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- January 1st, 1967
- Public Since
- March 25th, 1991
- No. of Employees
- 2,801
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 17,375,673
- Address
- 2 avenue de l ouest Lyonnais, RONTALON, 69510
- Web
- https://www.boiron.fr/
- Phone
- +33 478456100
- Contact
- Fabrice Rey
- Auditors
- Deloitte & Associes
Upcoming Events for BOI
Similar to BOI
AB Science SA
Euronext - Paris
Advicenne SA
Euronext - Paris
Aelis Farma SA
Euronext - Paris
Biocorp Production SA
Euronext - Paris
DBV Technologies SA
Euronext - Paris
FAQ
What is the Boiron SA share price?
As of Today at 07:03 UTC, shares in Boiron SA are trading at €39.00. This share price information is delayed by 15 minutes.
How has the Boiron SA share price performed this year?
Shares in Boiron SA last closed at €39.00 and the price had moved by -8.56% over the past 365 days. In terms of relative price strength the Boiron SA share price has underperformed the FTSE Global All Cap Index by -12.44% over the past year.
What are the analyst and broker recommendations for Boiron SA?
The overall consensus recommendation for Boiron SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Boiron SA dividend yield?
The Boiron SA dividend yield is 2.82% based on the trailing twelve month period.
Does Boiron SA pay a dividend?
Last year, Boiron SA paid a total dividend of €1.10, and it currently has a trailing dividend yield of 2.82%.Looking ahead, shares in Boiron SA are due to go ex-dividend on 2023-05-31 and the next dividend pay date is 2023-06-02.
When does Boiron SA next pay dividends?
Boiron SA are due to go ex-dividend on 2023-05-31 and the next dividend pay date is 2023-06-02. The historic dividend yield on Boiron SA shares is currently 2.82%.
How do I buy Boiron SA shares?
To buy shares in Boiron SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Boiron SA?
As of the previous close price of €39.00, shares in Boiron SA had a market capitalisation of €677.65m.
Where are Boiron SA shares listed?
Here are the trading details for Boiron SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: BOI
What kind of share is Boiron SA?
Based on an overall assessment of its quality, value and momentum Boiron SA is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Boiron SA share price forecast for 2023?
The analyst consensus target price for shares in Boiron SA is €48.70. That is 24.87% above the last closing price of €39.00.
Analysts covering Boiron SA currently have a consensus Earnings Per Share (EPS) forecast of €2.54 for the next financial year.
What is the trend in the Boiron SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Boiron SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -17.16%.
As of the last closing price of €39.00, shares in Boiron SA were trading -11.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Boiron SA PE Ratio?
The Boiron SA PE ratio based on its reported earnings over the past 12 months is 14.41. The shares last closed at €39.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Boiron SA?
Boiron SA's management team is headed by:
- Thierry Boiron - CHM
- Valerie Lorentz-Poinsot - CEO
- Jean-Christophe Michel Bayssat - DCE
- Jacky Abecassis - NED
- Laurence Boiron - NED
- Michele Boiron - NED
- Christine Boutin - NED
- Jean-Pierre Boyer - NED
- Christine Boyer-Boiron - NED
- Stephanie Chesnot - NED
- Anabelle Flory-Boiron - NED
- Bruno Grange - NED
- Virginie Heurtaut - NED
- Sylvain Mossaz - NED
- Gregory Walter - NED
- Michel Bouissou - NID